Filing Details
Lantern Pharma Inc. (NASDAQ:LTRN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:LTRN
Lantern Pharma Inc. (LTRN) Files Quarterly Report for Q0
Lantern Pharma Inc. (NASDAQ:LTRN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Lantern Pharma Inc. (NASDAQ:LTRN) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Lantern Pharma Inc. (NASDAQ: LTRN) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026.
- The company's stock trades at $2.65 per share with a market capitalization of $41.8 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, including updated risk factors and changes in business conditions since the last annual filing.
Market Context
Lantern Pharma Inc.'s stock currently trades at $2.65 with a market capitalization of $41.8M.
The 10-Q provides Lantern Pharma Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Lantern Pharma Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LTRN Stock Page
Frequently Asked Questions
Where can I read LTRN's SEC filings?
Browse all filings on our LTRN SEC filings page.
What types of SEC filings does Lantern Pharma Inc. file?
Public companies like Lantern Pharma Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.